Geode Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.67M Buy
919,893
+82,094
+10% +$682K ﹤0.01% 2674
2025
Q4
$8.73M Buy
837,799
+98,498
+13% +$988K ﹤0.01% 2475
2025
Q3
$6.65M Sell
739,301
-123,368
-14% -$1.08M ﹤0.01% 2640
2025
Q2
$11.2M Sell
862,669
-591
-0.1% -$8.89K ﹤0.01% 2288
2025
Q1
$21.8M Buy
863,260
+32,502
+4% +$966K ﹤0.01% 1860
2024
Q4
$28.6M Buy
830,758
+13,641
+2% +$615K ﹤0.01% 1764
2024
Q3
$40.4M Buy
817,117
+122,775
+18% +$6.29M ﹤0.01% 1563
2024
Q2
$41.8M Buy
694,342
+118,682
+21% +$6.78M ﹤0.01% 1473
2024
Q1
$29.7M Buy
575,660
+17,153
+3% +$842K ﹤0.01% 1690
2023
Q4
$22.5M Buy
558,507
+40,368
+8% +$1.18M ﹤0.01% 1834
2023
Q3
$14.5M Buy
518,139
+66,320
+15% +$1.98M ﹤0.01% 2031
2023
Q2
$13M Buy
451,819
+52,980
+13% +$1.18M ﹤0.01% 2129
2023
Q1
$6.65M Buy
398,839
+93,869
+31% +$1.33M ﹤0.01% 2497
2022
Q4
$3.86M Buy
304,970
+25,322
+9% +$308K ﹤0.01% 2788
2022
Q3
$3.35M Buy
279,648
+51,885
+23% +$713K ﹤0.01% 2889
2022
Q2
$3.21M Buy
227,763
+6,287
+3% +$82.9K ﹤0.01% 2941
2022
Q1
$2.74M Buy
221,476
+99,444
+81% +$1.19M ﹤0.01% 3093
2021
Q4
$1.37M Buy
122,032
+41,454
+51% +$498K ﹤0.01% 3556
2021
Q3
$1.02M Buy
+80,578
New +$1.11M ﹤0.01% 3661

Other funds holding RXST

Geode Capital Management's RXST Position: Q1 2026 in Review

Geode Capital Management increased its RxSight (RXST) stake by 9.8% in Q1 2026, buying an estimated $682K and bringing the position to 919,893 shares worth $5.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

Geode Capital Management first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $41.8M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Geode Capital Management held 919,893 shares of RxSight worth $5.67M as of Q1 2026.
  • Geode Capital Management bought 82,094 RxSight shares in Q1 2026, an estimated $682K.
  • RxSight made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2674 holding.
  • Geode Capital Management first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
  • Geode Capital Management's RxSight position peaked at $41.8M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.